HEMOPHILIA CARE and G.A.P PROGRAMME

Slides:



Advertisements
Similar presentations
Hemophilia Improving quality of life …until a cure…through L ower mortality I mproved outcomes F ewer hospitalizations E ducated independent patients.
Advertisements

Managing Sharps Waste In Cambodia SIGN Meeting, 25 October 2002 Cambodiana Hotel, Phnom Penh Dr. Chea Kim Ly, Deputy Director National Immunization Program.
REFORMS IN THE HEALTH CARE FINANCING The development OF health insurance system in albania ELVANA HANA GENERAL DIRECTOR III Balkanic Forum, Montenegro.
New Employee Orientation
“Getting to Zero: Thailand’s Experience with E-MTCT” Petchsri Sirinirund Advisor on HIV/AIDS Policy and Programme Department of Disease Control, Thailand.
Putnam County Hospital CANCER CENTER The Cancer Center is located on the 2 nd floor of Putnam County Hospital. Continuously Accredited by the American.
National Mental Health Programme. Govt of India integrated mental health with other health services at rural level. It is being implemented since 1982.
CCC Team Assessment of Care Coordination Capacity February 26, 2014 Care Coordination Collaborative California Institute for Mental Health Care Coordination.
CERVICAL CANCER: EARLY DETECTION, DIAGNOSIS & TREATMENT in LRS By Dr D. A. Kombe, MD, Mmed (Rad/onc) 2 nd East Africa WE CAN Breast & Cacx Advocacy, Education.
©2007 World Heart Federation … Updated October 2008 Diagnosis and Management of Acute Rheumatic Fever and Rheumatic Heart Disease.
UW H EALTH P RIMARY C ARE / B EHAVIORAL H EALTH I NTEGRATION U NITED W AY F ORUM September 22,
Missouri’s Primary Care and CMHC Health Home Initiative
Hemophilia Improving quality of life …until a cure…through L ower mortality I mproved outcomes F ewer hospitalizations E ducated independent patients.
Impact Evaluation of Health Insurance for Children: Evidence from Vietnam Proposal Presentation PEP-AusAid Policy Impact Evaluation Research Initiative.
California Children Services A Comprehensive Overview Barbara Sheehy, Administrator.
THANK YOU!. Regional Adviser, Noncommunicable Diseases, WHO/EMRO Dr Ibtihal Fadhil.
Progress and Plans for PPM in the Western Pacific Region Fifth PPM DOTS Subgroup Meeting Cairo, Egypt.
Health Referral System for Care of People with Disability Nguyen Hoang Nam, MD, MPH Welcome To Life Project Coordinator, Khanh Hoa, Viet Nam.
FINANCIAL OPTIONS FOR TB CONTROL IN MONGOLIA
2008© COPYRIGHT American Thrombosis & Hemostasis Network Maximizing Utilization of Lab Tracker Presenter: Ann Forsberg.
Nairobi, Kenya June 26, 2013 ROLE OF THE WFH, IN ACHIEVING TREATMENT FOR ALL.
Nepal Hemophilia Society : Established in 1992 in the leadership of Dr. Ranjan Singh Affiliation: World Federation of Hemophilia- WFH (1992) and National.
Action Plan Good Health Situation of Population in Capital of Myanmar Yangon Division By DR MYA THIDA AYE.
Developing Cardiac Rehabilitation in Vietnam Dr Juliette Hussey School of Medicine Trinity College Dublin Ireland.
National Support Team: Findings from the first 2 years Katrina Stephens Associate Delivery Manager, Alcohol Harm Reduction National Support Team, Department.
© Copyright, The Joint Commission Integration: Behavioral and Primary Physical Health Care FAADA/FCMHC August, 2013 Diana Murray, RN, MSN Regional Account.
Health Care Distribution, Ch. 7. United States Gross Domestic Product (GDP) in 2002 was 10 trillion dollars  1.6 trillion of it was spent on health care.
PROPOSAL FOR A MODEL MENTAL HEALTH COMMUNITY BASED SERVICE DELIVERY.
A baby will never know her mother’s touch How can you value this loss?
RUSSIAN HEMOPHILIA SOCIETY National member organization of the World Federation of Hemophilia Activity of the Russian Hemophilia Society in the Healthcare.
Planning and implementation of Tajikistan Victim Assistance Programme Reykhan MUMINOVA, Tajikistan Mine Action Center, VA Officer Central Asia Regional.
Pioneering IMAI: Developing an integrated approach in Uganda Dr Elizabeth Madraa, Program Manager National STD/AIDS Control Program MOH - UGANDA 5 th Dec.
Linda Devereux Associate Director Merseyside and Cheshire Cancer Network - why we are here and what’s next!
Chapter 7.2 Examination and Treatment Prepared by Nguyen Trong Khoa.
WFH WORK IN NIGERIA ENUGU, NIGERIA AUGUST 2014 Assad Haffar Deputy Programs Director 2012.
A baby will never know her mother’s touch How can you value this loss?
MEDICAL SERVICE ADMINISTRATION VIETNAM MINISTRY OF HEALTH
Health services philosophy
Public health impacts of donor screening for T. cruzi infection Susan P. Montgomery, DVM MPH Division of Parasitic Diseases Centers for Disease Control.
SEMFYC: Spanish Society of Family and Community Medicine. Miguel García Ribes, José Vicente Sorlí Guerola. SEMFyC’s working group on Clinical Genetics.
FREE STATE DEPARTMENT OF HEALTH Presentation on the Status of Conditional Grants Public Hearings on Conditional Grants 03 May 2006.
ARV Treatment Scale Up: Progress in Ukraine Andriy Klepikov Executive Director, International HIV/AIDS Alliance in Ukraine ARV Treatment Scale Up: Progress.
1 Strengthening PMTCT Data Reporting and Use through Supportive Supervision and Routine Performance Evaluation: Experiences from Dedza and Ntcheu Districts,
M O N T E N E G R O Negotiating Team for the Accession of Montenegro to the European Union Working Group for Chapter 28 – Consumer and Health Protection.
UPDATING OF HEMOPHILIA CARE IN VIETNAM VIETNAM HEMOPHILIA ASSOCIATION Dr. Nguyen Thi Mai, General Secretary of Vietnam Hemophilia Association 1/22.
Jana Feldmane Ministry of Health of Latvia Public Health Department Health care overview in prisons.
WFH Support to Indonesia
Sharing experience in treating with EHL product , Banjarmasin
Vietnam non communicable diseases prevention and control Program
Us Healthcare System.
WFH GAP Program Alain Weill, WFH President March 5, 2017.
CONTROLLING THE COSTS OF HEMOPHILIA
TB- HIV Collaborative activities in Romania- may 2006 status
Policies and Planning of Literacy and CLCs in Afghanistan
PAHO/WHO STRATEGY INTEGRATED HEALTH SYSTEM DELIVERY NETWORK
Birth & Death Notification System and How the Health Sector Contribution on CRVS in Lao PDR Dr. Founkham Rattanavong, Deputy Director General of Planning.
Health Home Program Services
EDC ©2016. All rights reserved.
Advancing Primary Care Delivery: Practical, Proven, and Scalable Approaches Chartpack UnitedHealth Center for Health Reform & Modernization September.
Effective and humane care for all with mental, neurological,
Community Collaboration A Community Promotora Model
Sudan’s Health Sector Reform; addressing the SDGs
Vietnam Investment and Finance for TB
”Supporting Parents Right from the Start”
Optum’s Role in Mycare Ohio
How will the NHS Long Term Plan work in our community?
YELLOW FEVER VACCINE AVAILABILITY AND NEEDS FOR THE AFRICAN REGION
Thank you for viewing this presentation.
Dr. Festus Njuguna Moi University/MTRH
Examining the Role of Pharmacokinetics in Hemophilia
Presentation transcript:

HEMOPHILIA CARE and G.A.P PROGRAMME VIETNAM HEMOPHILIA ASSOCIATION UPDATING OF HEMOPHILIA CARE and G.A.P PROGRAMME IN VIETNAM Dr. Nguyen Hoang Nam Board member of Vietnam Hemophilia Association Deputy Head of Clinical Haematology Department, National Children’s Hospital, Hanoi, Vietnam

In Vietnam: - GDP/capita: 2200 USD/year - Population: 93.4 mil (2016) - Number of PWH estimated: about 6158 - Number of patient diagnosed: 2550 ≈ 41.2%

7 Hemophilia Treatent Centers 2. National Chilren’s Hospital 1. NIHBT 5. Cho Ray Hospital 6. Children Hospital in Hochiminh City 3. Hue Central Hospital 4. Blood Transfusion and Hematology hospital in Hochiminh city 7. Can Tho Center hospital

Number of hemophilia patients 4/41

TYPE OF TREATMENT - Episodic bleeding treatment in the hospital: >95% Home treatment: some cases Prophylaxis in some indicated patients + Single dose + Low dose prophylaxis (several hemophilia patients under 15 years old) + Secondary prophylaxis for 1-3 months: after central nervous systems bleeding, target joint 5/41

BLOOD PRODUCTS Blood product home made: - Fresh frozen plasma; Plasma moved cryoprecipitate: Used for Hemophilia B; Cryoprecipitate: Used for Hemophilia A and vWD. 2. Import product: - Plasma derived FVIII and FIX concentrate: 8Y, Replenine (BPL), Hemofil – M, Immunine (Baxter), Octanat (Octapharma) FVIIa (Novo Seven) 3. Donation Drug - Eloctate, Alphante, Aprolix from WFH 6/41

Quantities of FVIII / F IX used across the country over the years (Unit: unit /people) 7/41 7/20

Mean global factor used 8/41 8/20

Comprehensive care Screening for inhibitors and virus transmission periodically Genetic diagnosis, carrier and Prenatal diagnosis Coordinate the related specialist: Dental, Rehabilitation, Physiotherapist, surgery, obstetric…

Education for patients and families 10/41

Education for patients and families 11/39

Training for medical staffs 12/41 12

Peer group meeting

New version of guideline Achievements in advocacy Insurance cover factor VIII national wide FVIIa and guideline for diagnosis and treatment hemophilia approved by MOH Insurance pay for hemophilia (except factor concentrate). September 2016 August 2007 2012 2009 March 2014 October 2005 Patient pay for treatment Factor IX Insurance pay for factor concentrate at NIHBT New version of guideline 14/41

Patient have to Co-payment the cost of treatment Voluntary insurance: co-payment of 20% cost of treatment   Poor coverage: co-payment of 5%   Insurance poor and the disabled: insurance cover 100% cost of treatment In the case of patients with co-payment of insurance for 5 consecutive years, if the co-payment the cost of treatment in the last year exceeded 7 million, they will be entitled to 100% coverage. The level of insurance cover: Depending on each hospital (Example In NIHBT: 250USD/outpatient, 820 USD/inpatient) . 15/41 15/17

NEW GUIDELINES ON DIAGNOSIS AND TREATMENT OF HEMOPHILIA Approved by Ministry of Health in September 2016. Contents: + Treatment of bleeding + Home treatment + Low dose prophylaxis (with severe hemophilia patient under 15 years old) + Secondary prophylaxis + Comprehensive care at some Hemophilia Centers + Treatment of bleeding for patients with inhibitors by pass agent and ITI + Genetics diagnostic and prenatal diagnosis 16/41

VIETNAM GLOBAL ALLIANCE FOR PROGRESS (GAP)

Signing ceremony MOU of Global Alliance for Progress (2016 – 2019) Time: 21th September, 2016 Venue: Thanh Hoa Province (in the National Scientific Conference on Hematology and Blood Transfusion with nearly 1000 participants). Signing ceremony between: + The World Federation of Hemophilia and the + National Institute of Hematology and Blood Transfusion

Signing ceremony MOU of GAP 19/41 19

Meeting on Vietnam GAP program Time: 13 – 14 February, 2017 Contents: Discuss on a specific plan of action for the GAP program in Vietnam. Joint meeting (include VHA, NNHF, WFH and IHS) to discuss on collaboration to join efforts to further improve hemophilia care in Vietnam Visit Hemophilia Centers in Hanoi

Meeting with WFH (13-14 February, 2017) Discuss on a specific plan of action for the GAP program in Vietnam.

Activities in Vietnam Time: WFH plan to visit Vietnam twice/year (in March and August) Venue: visit 2 cities each time. Content: - Assess the implementation of the activities of GAP Organize training course for medical staff in Vietnam about hemophilia. Organize training training course for patient organization

STEPS FOR DEVELOPING NATIONAL HEMOPHILIA CARE PROGRAME IN VIETNAM Government support: Presents Goals after 4 years Limited central or regional government resources allocated for hemophilia care. The Ministry of Health participate in, supports, facilitates for national hemophilia care program.

2. Care Delivery Presents Goals after 4 years There are 7 HTCs 6 comprehensive hemophilia care center 01 centers have team work meet the requirements of comprehensive care. Expanding at least 10 satellites -HTCs, Existed HTCs Expanding HTCs after 4 years

3. Medical Expertise 3.1. Laboratory Diagnosis: Presents Goals after 4 years The diagnosis of hemophilia only be done in big hospitals. Diagnostic capacity of local hospitals is still limited Provincial hospitals have basic laboratory diagnostic ability. 7 HTCs have vWD Assays and Inhibitor detection and participate in EQAS DNA detection are centralizing in 2 HTCs (NIHBT and BTH)

3.2. Medical Treatment 95% patients on demand treated in hospital. Present Goals after 4 years 95% patients on demand treated in hospital. Home care is not available Some case secondary prophylaxis - Home care available Primary prophylaxis for severe patients <15. - All hematologist in hospitals trained in hemophilia - Education offered to general medical community

4. Treatment Products Presents Goals after 4 years Combination of domestic production (cryo, FFP) and some purchase of plasma-derived factor concentrates CFCs: + Supplied not adequately + Used: 0.1 IU/ capita + Available only in the big hospitals Combination of local production of and purchase of plasma-derived factor concentrates + Supplied adequately, proper national tender system + Used: 0.5 – 1 ui/capita + At least 17 hospitals (HTC) have CFCs

5. Patient Organization Goals after 4 years: Outreach to detection 1.500 new patients. Establish 10 new Branches, Clubs, Groups of patients base on HTC. Patients are more active in the association's activities. National organization is a partner in national hemophilia care program.

6. Data collection Registry program only for single HTCs Presents Goals after 4 years Registry program only for single HTCs National registry program for all identified patients with bleeding disorders Design and conduct observational studies on bleeding disorders Participate in multi-center comparative research on people with bleeding disorders (if possible)

Thank you for your attention!